N-Benzyl-1-methylpiperidin-4-amine

Catalog No.: 
ACPRIY089
CAS No.: 
194538-07-3
Molecular Formula: 
C13H20N2
Molecular Weight: 
204.32
N-Benzyl-1-methylpiperidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$1239.001 week1 week

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Benzyl-1-methylpiperidin-4-amine
IUPAC NameN-benzyl-1-methylpiperidin-4-amine
MDL No.MFCD00480991
Molecular FormulaC13H20N2
Molecular Weight204.32
SMILESCN1CCC(NCC2=CC=CC=C2)CC1
InChI KeyRCMXNLSUDHVDJU-UHFFFAOYSA-N
SynonymBENZYL-(1-METHYL-PIPERIDIN-4-YL)-AMINE;4-Piperidinamine, 1-methyl-N-(phenylmethyl)-;1-methyl-N-(phenylmethyl)-4-piperidineamine;1-Methyl-N-(benzyl)-4-piperidineamine
CAS No.194538-07-3

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H312-H315-H318-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPRIY089 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACICYA027 route compound structure diagram
    ACICYA02737488-40-7In Stock
  4. Then
  5. ACPRIY089 route product structure diagram
    ACPRIY089194538-07-3
Inquiry

2. ACPRIY089 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTKMW158 route compound structure diagram
    ACTKMW158120088-53-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPRIY089 route product structure diagram
    ACPRIY089194538-07-3
Inquiry

3. ACPRIY089 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPRIY089 route product structure diagram
    ACPRIY089194538-07-3
Inquiry

Comments (0)